artemether has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adel, M; Ebrahimi, SA; Haeri, A; Mirzaei-Parsa, MJ; Najafabadi, MRH; Pazoki-Toroudi, H; Zahmatkeshan, M | 1 |
| Akbarian, A; Ebtekar, M; Hassan, ZM; Pakravan, N | 1 |
| Branquinho, RT; de Souza, A; Lanna, EG; Machado, MGC; Mosqueira, VCF; Siqueira, RP; Trindade, IC | 1 |
3 other study(ies) available for artemether and Breast Cancer
| Article | Year |
|---|---|
Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer.
Topics: Animals; Artemether; Breast Neoplasms; Female; Humans; Iran; Liposomes; Mice; Mice, Inbred BALB C | 2020 |
Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Topics: Artemether; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Folate Receptor 1; Folic Acid; Humans; Nanoparticles; Particle Size; Serum Albumin, Human | 2020 |
Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemether; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Survival; Docosahexaenoic Acids; Drug Carriers; Drug Compounding; Emulsions; Female; Humans; MCF-7 Cells; Nanocapsules; Neoplasm Metastasis; Triglycerides | 2021 |